...
首页> 外文期刊>European review for medical and pharmacological sciences. >The application of dexmedetomidine combined with dezocine in thoracoscopic radical resection of lung cancer and its effect on awakening quality of patients
【24h】

The application of dexmedetomidine combined with dezocine in thoracoscopic radical resection of lung cancer and its effect on awakening quality of patients

机译:Dexmedetomidine结合脱泽在胸腔镜根治症中的应用及其对患者觉得觉得觉得的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: The paper aims to explore the application of dexmedetomidine combined with dezocine in thoracoscopic radical resection of lung cancer and its effect on the awakening quality. PATIENTS AND METHODS: 122 patients undergoing thoracoscopic radical resection of lung cancer in The Affiliated Hospital of Qingdao University from April 2009 to January 2012 were selected as the subjects of the study. Among them, 68 patients were anesthetized with dexmedetomidine combined with dezocine as a study group, 54 patients with midazolam combined with fentanyl as a control group. The onset of anesthetic, operation time, awakening time, extubation time, and recovery time was compared. The mean arterial pressure (MAP), central venous pressure (CVP), and heart rate (HR) were compared before anesthesia (t0), at extubation (t1), 10 min after extubation (t2), and when patients left anesthesia recovery room (t3). The postoperative sedation score (Ramsay), modified the objective pain score (MOPS), and the pediatric anesthesia emergence delirium (PAED) score were compared at the time of the postoperative awakening (b1), 30 min after awakening (b2), 1 hour after awakening (b3), and 3 hours after awakening (b4). RESULTS: There was no significant difference in MAP, CVP, and HR between the study group and the control group at t0 (p 0.05). The scores of PAED at b3 and b4 in the study group were lower than those in the control group (p 0.05). CONCLUSIONS: The anesthesia effect of dexmedetomidine combined with dezocine in thoracoscopic radical resection of lung cancer is better and safer than other drugs, and it can produce good sedation and analgesic effect.
机译:目的:旨在探讨Dexmedetomidine与Dezocine在胸腔诊断切除肺癌中的应用及其对唤醒质量的影响。患者及方法:从2009年4月到2012年4月,青岛大学附属医院接受肺癌肺癌的122例患者被选为2012年1月作为该研究的主题。其中,68名患者用Dexmedetomidine麻醉了与Dezocine作为一项研究组,54例Midazolam患者与芬太尼作为对照组。比较麻醉,操作时间,唤醒时间,拔管时间和恢复时间的发作。在麻醉(T0),在拔管后(T1),在拔管后10分钟(T2),以及患者留下麻醉恢复室(t3)。术后镇静分数(Ramsay),修改了客观疼痛评分(MOP),在急剧唤醒(B1)的时间,在唤醒(B2)后30分钟的时间比较了小儿麻醉出苗谵妄(Paed)得分,1小时觉醒(B3)后,觉醒后3小时(B4)。结果:研究组和T0的对照组之间的地图,CVP和HR没有显着差异(P> 0.05)。研究组B3和B4的评分低于对照组(P <0.05)。结论:Dexmedetomidine的麻醉效应与肺癌切除肺癌中的脱氮术比其他药物更强,更安全,可以产生良好的镇静和镇痛作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号